Please login to the form below

Not currently logged in
Email:
Password:

Cytori appoints David Rickey as chairman

Replaces Lloyd Dean who will concentrate on CEO position at Dignity Health

David Rickey, Cytori San Diego-based Cytori Therapeutics has named David Rickey as the successor to its current chairman of the board Lloyd Dean.

Rickey brings more than a decade of experience with Cytori to the position, having served on the board of directors at the cell therapy-focused biotech for 13 years.

In addition to this role, he has served in several senior positions over the course of the past few years, primarily at technology companies.

This includes periods as president, CEO and chairman of Applied Micro Circuits Corporation; director of AMI Semiconductor; and director of Netlist.

His predecessor as Cytori chairman, Dean, will continue to serve as an independent member of the board of directors in addition to his role as president and CEO of healthcare provider Dignity Health.

According to Cytori, Dean requested the move to cope with Dignity Health's preparations for the implementation of the Affordable Care Act in the US in 2014.

“We are grateful to Mr Dean for his leadership and service as Chairman for the past two years, and look forward his continued service to Cytori and our shareholders into the future,” said Chris Calhoun, CEO of Cytori.

11th July 2013

From: Research, Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Langland

Langland, a Publicis Health company, is the only health communications agency that thinks further across Clinical Trial Experience, Medical Strategy...

Latest intelligence

How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....